Dry age-related macular degeneration

Results 11 to 20 of about 18,555 (176)

Delhi Journal of Ophthalmology
Age-related macular degeneration (AMD) is a leading cause of irreversible central vision loss in people over 55 years, driven by age-related changes in the retinal pigment epithelium, Bruch’s membrane, and choriocapillaris that impair waste clearance and
Bhanu Priya +3 more
doaj +2 more sources

Nutrient supplementation for age-related macular degeneration, cataract, and dry eye

Journal of Ophthalmic & Vision Research, 2014
There have been enormous advances in the past decade for the treatment of age-related macular degeneration (AMD); however, these treatments are expensive and require frequent follow-up and injections which place a tremendous burden on both the healthcare
Ronald P Hobbs, Paul S Bernstein
doaj +3 more sources

Recent developments in the management of dry age-related macular degeneration

Clinical Ophthalmology, 2015
Elisa Buschini, Antonio M Fea, Carlo A Lavia, Marco Nassisi, Giulia Pignata, Marta Zola, Federico M Grignolo Ospedale Oftalmico, Ophthalmic Section, Department of Clinical Pathophysiology, University of Turin, Turin, Italy Abstract: Dry age-related ...
Buschini E +6 more
doaj +6 more sources

Treatment of Dry Age-Related Macular Degeneration [PDF]

Ophthalmic Research, 2014
A number of different approaches are under development for treating nonexudative manifestations of age-related macular degeneration (AMD). Some interventions target specific pathways that are believed to play a role in AMD pathogenesis, e.g. oxidative damage, lipofuscin accumulation, chronic inflammation (including complement activation), extracellular
Querques G +7 more
openaire +5 more sources

Recent Advances in Age-Related Macular Degeneration Therapies

Molecules, 2022
Age-related macular degeneration (AMD) was described for the first time in the 1840s and is currently the leading cause of blindness for patients over 65 years in Western Countries. This disease impacts the eye’s posterior segment and damages the macula,
Marie Fabre +7 more
doaj +1 more source

Multimodal imaging of dry age‐related macular degeneration [PDF]

Acta Ophthalmologica, 2012
Abstract.Purpose: The purpose of this study was to understand clinical significance of near‐infrared reflectance (NIR), blue fundus autofluorescence (FAF) and near‐infrared autofluorescence (NIA) in dry age‐related macular degeneration (AMD), by correlation with fluorescein angiography (FA) and cross‐sectional spectral domain optical coherence ...
Forte R +5 more
openaire +5 more sources

New Discoveries in Retinal Cell Degeneration and Retinal Diseases

Biomolecules, 2023
Age-related macular degeneration (AMD) has two phenotypes: dry AMD and wet AMD [...]
Puran S. Bora
doaj +1 more source

Novel approach to antiangiogenic factors in age-related macular degeneration therapy

Central European Journal of Immunology, 2022
Age-related macular degeneration (AMD) is a leading cause of irreversible vision loss among the population above 85 worldwide. There are two main types of AMD: neovascular and dry AMD.
Katarzyna Samelska +4 more
doaj +1 more source

New Frontiers in Retina: highlights of the 2020 angiogenesis, exudation and degeneration symposium

International Journal of Retina and Vitreous, 2020
We summarize the most important findings presented at the 2020 angiogenesis, exudation and degeneration symposium in five topic areas: (1) epidemiology of retinal vascular disease and macular degeneration; (2) dry AMD and geographic atrophy; (3 ...
Carmen A. Puliafito, Charles C. Wykoff
doaj +1 more source

, 2016
Age-related macular degeneration (AMD), the most common form of irreversible blindness in the industrially developed world, can present years before a patient begins to lose vision. For most of these patients, AMD never progresses past its early stages to the advanced forms that are principally responsible for the vast majority of vision loss. Advanced
Charles B, Wright, Jayakrishna, Ambati
openaire +2 more sources

photobiomodulation
oxidative stress